The chart setup looks insane right now! Wedge breakout is confirming, big accounts are starting to take positions.. ETH momentum taking over! 🔥
TL;DR Breakdown:
What is CHAD? DeFi Development Corp (Nasdaq: DFDV) announced a new Series C Variable Rate Perpetual Preferred Stock.
The Yield: 13% annual dividend paid daily ($10 par value, contemplated ~$9 issue price = ~14.4% effective starting yield).
Solana-Backed: Backed by SOL treasury (staking yield + validator operations) to cover dividends organically without relying solely on common equity issuance.
Intelligent Leverage: Designed to grow SOL-per-share while avoiding margin calls and forced liquidation risks.
Coverage & Safety: Estimated ~$25M annualized organic revenue vs. ~$13M debt/preferred obligations. Built to withstand 25%–50% SOL price drops.
Check out the full presentation video for all the details!
I think we're headed for $200-$225 (supercycle trendline) before the next pullback
Another 19K SOL locked into the treasury!
2.333M SOL total holdings.. total flywheel momentum
Outperforming Nasdaq by 33% QTD.. pure alpha
1.8x operational leverage over spot.. unmatched exposure
The treasury strategy is compounding fast.. $DFDV is playing an entirely different game right now! 💎🙌
DAT Companies are taking over.
The market is shifting.
This is the big play.
Are you positions set? Is your strategy locked in?
BitMine ($BMNR) just released another massive weekly update.. Added 7,391 $ETH in 7 days, repurchased 3.0M shares this week alone, and total holdings reached $11.6 BILLION! We are now holding 4.8% of all Ethereum in existence.. almost at the "Alchemy of 5%" goal! 🚀🔥
📊 TREASURY BREAKDOWN
🔹 5,805,238 $ETH (Now holding 4.8% of total ETH supply!)
🔹 209 $BTC
🔹 $104M Cash & Marketable Securities
🔹 $180M Beast Industries
🔹 $69M Eightco ($ORBS)
💰 Total Crypto, Cash & Strategic Holdings: $11.6 BILLION
🔥 SHARE BUYBACK ENGINE IN FULL EFFECT
🔹 3.0M $BMNR shares repurchased this week alone!
🔹 19.1M total shares repurchased since July 1st!
Management is aggressively reducing share float while hoovering up $ETH at the same time.. The ETH-per-share ratio is compounding fast! 📈
🧠 WHY THIS IS INSANELY BULLISH FOR $BMNR:
All the negative comments and FUD are coming from people who clearly haven't done their homework and don't understand what this company is actually doing..
$MBOT is currently trading at a massive discount! The analyst price targets are not detached from reality at all, they actually reflect the potential here once key milestones hit.
Ignore the short-term noise and the bear chatter.. patience will pay off! 🚀
Microbot Medical ($MBOT) just dropped their Q2 2026 press release.. and the numbers are absolutely insane!
Here is the quick TL;DR on why this thing is primed to explode:
Massive Growth: Over 100% growth in revenue and new customers quarter-over-quarter (Q2 vs Q1 2026).. the full market release of their LIBERTY Robotic System in April is paying off big time!
Expansion mode: They already expanded from 4 to 8 sales territories, planning to hit 12 across the U.S. by the end of the year.. plus they just got clearance to enter international markets (starting with Israel)!
Big Government Contracts: They signed a deal to bring their tech into federal healthcare systems.. we are talking Veterans Affairs (VHA), Military Health System (MHS), and Indian Health Service (IHS).
Scaling Up Production: They just secured a second manufacturing site to handle the surging demand.. which means massive long-term margin expansion as volumes scale up.
Procedure volumes are rising, health systems are adopting this single-use robotic tech like crazy, the pipeline is stacked..
Are we loading up on shares before the market fully prices this in? What are your thoughts? 📈🤖
Q2 just closed.. positions are locked.. and corporate balance sheets are loaded!
Check your seatbelts, family.. this rocket is leaving the atmosphere!
Drop your top Q3 DAT picks below! 👇 To the moon! 🌕
Sitting at $0.82 right now.. absolute crazy, once-in-a-lifetime opportunity before the big Solana jump! Do not sleep on this entry level.. numbers do not lie!
Hey guys..
*updating this because it didn't even scratch the surface of how massive this tech actually is!*
MBOT’s LIBERTY system targets complex vascular procedures that are a massive pain for both doctors and patients. This isn't just a lab concept—it was tested by the absolute best research-doctors in top-tier world-class hospitals (including Memorial Sloan Kettering).
Look at these perfect metrics from the official ACCESS-PVI report.. absolutely flawless:
• 100% successful robotic navigation in all cases.. zero switching to manual manipulation!
• 0% adverse device effects reported.. a perfect safety profile!
• 92% relative reduction in radiation exposure for the operator!
• Maximum 5/5 performance score from investigators on ease of use, tool stability, and overall satisfaction!
But here is the real kicker that Wall Street doesn't know how to price yet: LIBERTY is the first miniaturized, portable, single-use endovascular robotic system on the market. It completely eliminates the millions in upfront costs and massive physical footprint required by old capital equipment.
Because it's a disposable, single-use device, it's a pure razor-and-blade recurring revenue model!
Every single procedure means a new sale!
Right now it’s approved for vascular/blood-clot adjacent procedures, but they are already successfully testing it for massive routine monitoring applications like Prostate cancer screenings.
The TAM expansion here is just ridiculous.
This company is introducing a brand new class of robots.. At ~$1.87 right now, the market is completely mispricing this asset. It's stupid cheap. A rare ground-floor entry point before the entire market wakes up and sends it to the moon..
Don't miss this ride!! 🚀🚀